Academic Journal
Q1Apoptosis
About Apoptosis
Apoptosis is a scholarly journal published by Springer. SCImago 2025 lists it in Q1, with an SJR of 2.242 and H-index of 138.
Coverage: 1996-2026. Research categories: Biochemistry (medical) (Q1); Cancer Research (Q1); Cell Biology (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1).
Verified field sources
- Journal Impact Factor: 9.0 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Arjan W. Griffioen PhD; Patrycja Nowak-Sliwinska PhD, DSc (Editors-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Cell death mechanisms and regulation; Autophagy in Disease and Therapy; Cancer-related Molecular Pathways; Mitochondrial Function and Pathology; RNA Interference and Gene Delivery; Phagocytosis and Immune Regulation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
5,090.00 USD; 3,990.00 EUR; 3,190.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
The role of vitamin D signalling in β cell apoptosis: a systematic review
Donglai Li, Nick Norris, Yousun An, Jenny E. Gunton et al.
2026-10 · DOI: 10.1007/s10495-026-02453-5Ru3: a novel ruthenium-based compound overcomes cisplatin resistance in non-small cell lung cancer via the E2F2-IGFBP3-GPX4 pathway
Yiting Lu, Shiming Wu, Ying Jiang, Meishu Wang et al.
2026-10 · DOI: 10.1007/s10495-026-02447-3Metabolic vulnerabilities in multiple myeloma: targeting iron and amino acid metabolism to induce ferroptosis
Qi Li, Weimin Zhang, Guangcan Gao, Yilei Shi et al.
2026-10 · DOI: 10.1007/s10495-026-02449-1The role of lysosome-dependent cell death in cancer
Jia-Feng Li, Ke Zhang, Xiao-Han Zhang, Xue-Chun Qu et al.
2026-10 · DOI: 10.1007/s10495-026-02442-8Anastasis: an unwelcome guest in cancer therapy
Yizhi Luo, Yong Lei, Jianmin Deng, Yi Yu et al.
2026-10 · DOI: 10.1007/s10495-026-02455-3Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives
Guanyu Zhu, Hangbiao Zhang, Yuanan Li, Wenjie Ma et al.
2026-10 · DOI: 10.1007/s10495-026-02425-9The ferroptosis–cuproptosis crosstalk in hematological malignancies: multi-omics insights into gene-regulated cell death and emerging therapeutic opportunities
Sonakshi Antal, Tushar Anshu, Pawan Kumar Goswami, Dinesh Kumar et al.
2026-10 · DOI: 10.1007/s10495-026-02451-7DONSON links tumor-cell survival to MIF-associated macrophage remodeling in small cell lung cancer
Qingwu Du, Rui Li, Ting Mei, Shuxiang Ma et al.
2026-10 · DOI: 10.1007/s10495-026-02441-9The cGAS-STING pathway: mechanistic basis, dual biological functions and translational therapeutic advances
Minjue Shan, Yan Liao, Ziyou Lin, Lizhou Song et al.
2026-10 · DOI: 10.1007/s10495-026-02450-8HPRT1 drives mitochondrial metabolic reprogramming and immunosuppressive microenvironment in oral squamous cell carcinoma
Qilin Hu, Wenhan Liu, Xiangyu Chen, Shuyi Wang et al.
2026-10 · DOI: 10.1007/s10495-026-02454-4SUCLG2 contributes to platinum resistance in lung adenocarcinoma through enhancing succinylation of GAC and glutamine metabolism
Zuorui Wang, Hui Wang, Lei Wang, Jiayuan Chen et al.
2026-10 · DOI: 10.1007/s10495-026-02443-7Targeting LAMP2 synergizes with gemcitabine to inhibit bladder cancer progression via modulating STING degradation and regulating macrophage phenotypes
Yue Lv, Qiang Yin, Wuheng Li, Leihong Deng et al.
2026-10 · DOI: 10.1007/s10495-026-02446-4The emerging roles of disulfidptosis in cancer
Yong-Hao Zhu, Yi-Xuan Liu, Yu-Xiang Liu, Cun-Yuan Yu et al.
2026-10 · DOI: 10.1007/s10495-026-02444-6GLG1 in cancer-associated fibroblasts promotes bladder cancer growth while limiting tumor apoptosis
Jingpeng Liu, Zhongbao Zhou, Baining Zhang, Runze Liu et al.
2026-10 · DOI: 10.1007/s10495-026-02439-3Lactylation and regulated cell death: the substrate defines the outcome
Shanjie Luan
2026-10 · DOI: 10.1007/s10495-026-02445-5GOLPH3-mediated sialylation of CXCR4 drives malignant progression and M2 macrophage polarization in colorectal cancer
Wangwu Liu, Yi Qiu, Ling Zeng, Yuze Wu et al.
2026-10 · DOI: 10.1007/s10495-026-02421-zDrugging small-molecule compounds in autophagy-dependent cell death to overcome cancer therapy resistance
Zhiqi Peng, Xiong Pei, Ruohan Gao, Dongbo Wu et al.
2026-10 · DOI: 10.1007/s10495-026-02437-5Berberine shows potential in mitigating PM2.5-induced breast cancer progression by inducing DNA damage and inhibiting error-prone DNA repair pathways
Anadi Bisht, Aishwarya Jaiswal, Rana P. Singh, Sagnik Dey et al.
2026-10 · DOI: 10.1007/s10495-026-02423-xActivating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death
Xinyun Zhang, Zhiming Wang, Yilei Shi, Qi Li et al.
2026-10 · DOI: 10.1007/s10495-026-02426-8Lactate-associated H3K18la upregulates RNF166 to promote immune evasion in hepatocellular carcinoma by remodeling c-Jun ubiquitination
Bingyi Ren, Yichen Yang, Kai Sheng, Qiuyu Mu et al.
2026-09 · DOI: 10.1007/s10495-026-02435-7Reviews
Community Reviews
Version History
September 23, 2026 at 8:51 pm
September 22, 2026